Filing Details

Accession Number:
0001415889-24-011190
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-18 21:43:32
Reporting Period:
2024-04-17
Accepted Time:
2024-04-18 21:43:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1717425 Adrian Haigh C/O Fennec Pharmaceuticals, Inc.
Po Box 13628, 68 Tw Alexander Drive
Research Triangle Park NC 27709
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-04-17 22,222 $2.31 22,222 No 4 S Direct
Common Shares Acquisiton 2024-04-18 22,222 $2.31 44,444 No 4 S Direct
Common Shares Disposition 2024-04-17 22,222 $9.91 22,222 No 4 S Direct
Common Shares Disposition 2024-04-18 22,222 $9.62 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Options Common Shares Disposition 2024-04-17 22,222 $2.31 22,222 $2.31
Options Common Shares Disposition 2024-04-18 22,222 $2.31 22,222 $2.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
449,135 2014-04-25 2024-04-25 No 4 M Direct
426,913 2014-04-25 2024-04-25 No 4 M Direct
Footnotes
  1. Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
  2. Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
  3. Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
  4. Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
  5. Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
  6. Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.